| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/24/2002 | US6455045 Immunogenic compounds with in particular an anti-cytokine effect, preparation process, pharmaceutical compositions and kits containing them |
| 09/24/2002 | US6455044 5c8 antigen |
| 09/24/2002 | US6455043 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody |
| 09/24/2002 | US6455042 Method of treating ulcerative colitis or crohn's disease by administering an antibody toαEβ7 integrin |
| 09/24/2002 | US6455041 Immunogenic epitopes of the human zona pellucida protein (ZP1) |
| 09/24/2002 | US6455040 Sometimes referred to as ?tnfr-5? or ?tr5,? and now referred to hereinafter as ?trail receptor without intracellular domain? or ?trid.? |
| 09/24/2002 | US6455039 An isolated nucleic acid molecule that hybridizes under stringent hybridization conditions with macrophase migration inhibiatory factor (mif) gene selected from dirofilaria immitis mif gene and onchocerca volvulus mif gene |
| 09/24/2002 | US6455037 Transgenic cells express nucleic acid molecules encoding functional recombinant alpha-galactosidase a enzyme |
| 09/24/2002 | CA2096223C Treatment for tissue ulceration |
| 09/24/2002 | CA2065325C Cdr grafted anti-cea antibodies and their production |
| 09/20/2002 | CA2715100A1 A novel receptor trem(triggering receptor expressed on myeloid cells) and uses thereof |
| 09/19/2002 | WO2002073213A2 Assay |
| 09/19/2002 | WO2002072852A2 Leporipox-based vector vaccines |
| 09/19/2002 | WO2002072850A1 Activated dual specificity lymphocytes and their methods of use |
| 09/19/2002 | WO2002072845A2 Salmonella promoter for heterologous gene expression |
| 09/19/2002 | WO2002072836A2 Replication-competent molecular clones of porcine endogenous retrovirus class a and class b derived from pig and human cells |
| 09/19/2002 | WO2002072835A1 Use of flavivirus for the expression of protein epitopes and development of new live attenuated vaccine virus to immune against flavivirus and other infectious agents |
| 09/19/2002 | WO2002072833A1 Cloning of the cdna that codes for cup s 1, the major allergen of cupressus sempervirens |
| 09/19/2002 | WO2002072832A2 Therapeutic binding molecules |
| 09/19/2002 | WO2002072830A2 Proteins associated with cell growth, differentiation, and death |
| 09/19/2002 | WO2002072805A2 Thymidylate synthase |
| 09/19/2002 | WO2002072802A2 Live attenuated strains of prrs virus |
| 09/19/2002 | WO2002072798A1 Fas ligand-expressing hematopoietic cells for transplantation |
| 09/19/2002 | WO2002072796A2 Continuous, normal human t-lymphocyte cell lines comprising a recombinant immune receptor with defined antigen specificity |
| 09/19/2002 | WO2002072793A2 Expression of properly folded and soluble extracellular domain of a gonadotropin receptor |
| 09/19/2002 | WO2002072792A2 Heterologous fusion protein constructs comprising a leishmania antigen |
| 09/19/2002 | WO2002072790A2 Tsg101-gag interaction and use thereof |
| 09/19/2002 | WO2002072785A2 Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer |
| 09/19/2002 | WO2002072780A2 Igf antagonist peptides |
| 09/19/2002 | WO2002072766A2 Induction of tumor immunity by variants of folate binding protein |
| 09/19/2002 | WO2002072754A2 Mva expressing modified hiv envelope, gag, and pol genes |
| 09/19/2002 | WO2002072637A1 Natural antibodie active against hiv virus |
| 09/19/2002 | WO2002072636A2 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 09/19/2002 | WO2002072627A2 Induction of anti-tumor cytotoxic t-lymphocytes in humans using peptide epitopes found by computer based algorithms for vaccination |
| 09/19/2002 | WO2002072625A1 The preparation and usage of plasmodium fusion antigen |
| 09/19/2002 | WO2002072623A1 Genes and proteins, and their use |
| 09/19/2002 | WO2002072622A2 Vaccine antigens against infection by chlamydia trachomatis |
| 09/19/2002 | WO2002072616A2 Transfection complexes |
| 09/19/2002 | WO2002072610A2 Rbp1l1, a novel retinoblastoma binding protein-related gene encoding an antigenic epitope and methods of using thereof |
| 09/19/2002 | WO2002072608A2 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW-AFFINITY FCηRECEPTORS |
| 09/19/2002 | WO2002072606A2 Epitope testing using hla |
| 09/19/2002 | WO2002072600A2 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| 09/19/2002 | WO2002072596A1 Steap-related protein |
| 09/19/2002 | WO2002072142A2 Modulation of a balance between the gut mucosal immune system and the intestinal microflora |
| 09/19/2002 | WO2002072140A2 Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo; analysis of vaccinating composition in vitro |
| 09/19/2002 | WO2002072139A1 Avian vaccine effective against infectious bursal disease virus |
| 09/19/2002 | WO2002072127A2 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof |
| 09/19/2002 | WO2002072030A2 High affinity integrin polypeptides and uses thereof |
| 09/19/2002 | WO2002072026A2 In situ langerhans cell vaccine |
| 09/19/2002 | WO2002072015A2 M cell directed vaccines |
| 09/19/2002 | WO2002072013A2 Method of treating malignancies through induction of blood immune responses |
| 09/19/2002 | WO2002072012A2 A novel proteosome-liposaccharide vaccine adjuvant |
| 09/19/2002 | WO2002072011A2 Stabilized therapeutic and imaging agents |
| 09/19/2002 | WO2002072008A2 Method for treating cancer using a33 specific antibodies and chemotherapeutic agents |
| 09/19/2002 | WO2002055663A3 Srebp pathway modulation through targeting hisrs |
| 09/19/2002 | WO2002055549A3 Systems for expression of heterologous proteins in m. capsulatus |
| 09/19/2002 | WO2002053184A3 Uses for polycationic compounds as vaccine adjuvants |
| 09/19/2002 | WO2002053181A8 Enterohemorragic escherichia coli vaccine |
| 09/19/2002 | WO2002050119A3 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 09/19/2002 | WO2002048391A3 Dormancy - induced mycobacterium proteins |
| 09/19/2002 | WO2002033119A9 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 09/19/2002 | WO2002022825A9 The c. albicans tec1 gene (catec1) and the coded tec1p protein |
| 09/19/2002 | WO2002017949A9 Novel functions for dp214 |
| 09/19/2002 | WO2002014355A3 Novel mitogen activated kinase |
| 09/19/2002 | WO2002012503A8 Production in pichia pastoris yeast and system for purifying the recombinant allergen of olea europaea ole e 1 for utilization in the diagnosis and treatment of allergies |
| 09/19/2002 | WO2002012456A3 Ampk-related serine/threonine kinase, designated snark |
| 09/19/2002 | WO2002012289A3 Stabilization of immunogens derived from paramyxoviruses |
| 09/19/2002 | WO2002010382A9 Trp8, trp9 and trp10, markers for cancer |
| 09/19/2002 | WO2002010379A3 Modified cea and uses thereof |
| 09/19/2002 | WO2002004953A3 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
| 09/19/2002 | WO2002004664A9 Genes comprising coding mononucleotide microsatellites or dinucleotide microsatellites that can be isolated from tumour cells |
| 09/19/2002 | WO2001092525A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/19/2002 | WO2001090185A3 Pt32 sperm protein, sperm c-yes, oocyte cytoplasmic c-yes, and uses thereof |
| 09/19/2002 | WO2001085208A8 Molecular antigen arrays and vaccines |
| 09/19/2002 | WO2001083783A3 In vivo loading of mhc |
| 09/19/2002 | WO2001081379A3 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/19/2002 | WO2001064949A3 Diagnostics and therapeutics for glaucoma |
| 09/19/2002 | WO2001036630A9 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
| 09/19/2002 | WO2001035899A9 Inhibitors of helicobacter pylori induced gastrointestinal diseases |
| 09/19/2002 | WO2001007483A9 Prognosis and therapy of malignant diseases by antibodies which bind phosphorylated met protein |
| 09/19/2002 | WO1997046589A3 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods |
| 09/19/2002 | US20020133834 Test and model for alzheimer's disease |
| 09/19/2002 | US20020133000 Neuronal protein for use in inducing sleep and for treatment of sleep disorders |
| 09/19/2002 | US20020132994 Nucleotide sequences coding polypeptide for use in the treatment and prevention of microorganismal infections |
| 09/19/2002 | US20020132979 Monoclonal antibody for use in the diagnosis, prevention and treatment of tumors |
| 09/19/2002 | US20020132978 VEGF-modulated genes and methods employing them |
| 09/19/2002 | US20020132976 Immunogenic peptides derived from prostate-specific antigen (PSA) and uses thereof |
| 09/19/2002 | US20020132789 Especially for rickettsial pathogen selected from the group consisting of Rickettsia spp., Ehrlichia spp., Anaplasma spp., and Cowdria |
| 09/19/2002 | US20020132781 Optionally a glutathione pathway enhancing and detoxifying compound, particularly cystine |
| 09/19/2002 | US20020132778 Modulating angiogenesis |
| 09/19/2002 | US20020132771 Binding agent that specifically binds to both soluble and tumor-bound tumor- associated MUC-1 and that is effective in therapeutically treating a mammal having a tumor that expresses a tumor- associated MUC-1. |
| 09/19/2002 | US20020132347 Genetically engineered cell for use in the diagnosis, prevntion and treatment of viral diseases |
| 09/19/2002 | US20020132337 Processes for preparation of marek's disease virus using continuous avian cell lines |
| 09/19/2002 | US20020132334 Nucleotide sequences coding preferential polypeptide for use in the treatment of tumors and nervous system disorders |
| 09/19/2002 | US20020132330 Polypeptide for use in the treatment, prevention and diagnosis of inflammation, cell proliferation and apoptosis |
| 09/19/2002 | US20020132324 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/19/2002 | US20020132275 Methods for detecting the efficacy of anticancer treatments |
| 09/19/2002 | US20020132237 Detecting ovarian cancer humans; obtain sample, incubate with preferential oligonucleotides, monitor hybridization, compare to control, evaluate for cancer |
| 09/19/2002 | US20020131984 Immunogenic conjugates comprising a group B meningococcal porin and an H. influenzae polysaccharide |
| 09/19/2002 | US20020131983 Method for inducing an immunological response in a host by administering to the host at least one antigen and a lipoprotein |